Adamis Pharmaceuticals | Eiendeler

Assets Endring Dato
Adma Biologics USD 329.18M 19.81M 2023-12
Clal Biotechnology ILS 182.69M 6.18M 2022-12
Compugen USD 67.61M 9.44M 2023-09
CSL USD 36.23B 786.4M 2023-06
Grifols EUR 22.06B 631.75M 2023-09
RedHill Biopharma USD 35.04M 23.8M 2023-06



Adamis Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.